Quantitative Proteomics of Bronchoalveolar Lavage Fluid in Lung Adenocarcinoma

Cancer Genomics - Proteomics

DODIE S. POUNIOTIS¹  SALEH A. ALMATROODI³  CHRISTINE F. MCDONALD²  IAN A. DARBY¹  ALLISON L. COLLINS² 

[1] Cancer and Tissue Repair Laboratory, School of Medical Sciences, RMIT University, Bundoora, VIC, AustraliCancer and Tissue Repair Laboratory, School of Medical Sciences, RMIT University, Bundoora, VIC, AustraliCancer and Tissue Repair Laboratory, School of Medical Sciences, RMIT University, Bundoora, VIC, Australi;Institute for Breathing and Sleep, Austin Health, Heidelberg, VIC, AustraliInstitute for Breathing and Sleep, Austin Health, Heidelberg, VIC, AustraliInstitute for Breathing and Sleep, Austin Health, Heidelberg, VIC, Australi;Cancer and Tissue Repair Laboratory, School of Medical Sciences, RMIT University, Bundoora, VIC, AustraliApplied Medical Sciences College, Qassim University, Buraidah, Saudi ArabiCancer and Tissue Repair Laboratory, School of Medical Sciences, RMIT University, Bundoora, VIC, AustraliCancer and Tissue Repair Laboratory, School of Medical Sciences, RMIT University, Bundoora, VIC, AustraliApplied Medical Sciences College, Qassim University, Buraidah, Saudi ArabiApplied Medical Sciences College, Qassim University, Buraidah, Saudi ArabiCancer and Tissue Repair Laboratory, School of Medical Sciences, RMIT University, Bundoora, VIC, AustraliApplied Medical Sciences College, Qassim University, Buraidah, Saudi Arabi

关键词: Lung adenocarcinoma;    mass spectrophotometry;    quantitative proteomics;    BALF;    protein;    biomarker;   

DOI  :  

来源: Delinasios GJ CO

【 摘 要 】

Background: The most commonly reported primary lung cancer subtype is adenocarcinoma, which is associated with a poor prognosis and short survival. Proteomic studies on human body fluids such as bronchoalveolar lavage fluid (BALF) have become essential methods for biomarker discovery, examination of tumor pathways and investigation of potential treatments. Aim: This study used quantitative proteomics to investigate the up-regulation of novel proteins in BALF from patients with primary lung adenocarcinoma in order to identify potential biomarkers. Materials and Methods: BALF samples from individuals with and without primary lung adenocarcinoma were analyzed using liquid chromatography-mass spectrometry. Results: One thousand and one hundred proteins were identified, 33 of which were found to be consistently overexpressed in all lung adenocarcinoma samples compared to non-cancer controls. A number of overexpressed proteins have been previously shown to be related to lung cancer progression including S100-A8, annexin A1, annexin A2, thymidine phosphorylase and transglutaminase 2. Conclusion: The overexpression of a number of specific proteins in BALF from patients with primary lung adenocarcinoma may be used as a potential biomarker for lung adenocarcinoma.

【 授权许可】

Unknown